Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 3/20 | 0.67 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.67 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.67 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.67 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.67 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.65 |
| ▸ | PKM | P14618 | 2/20 | 0.65 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.65 |
| ▸ | ALOX5 | P09917 | 5/20 | 0.62 |
| ▸ | STAT3 | P40763 | 3/20 | 0.62 |
| ▸ | NFE2L2 | Q16236 | 3/20 | 0.62 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.62 |
| ▸ | NFKB2 | Q00653 | 2/20 | 0.62 |
| ▸ | RELA | Q04206 | 2/20 | 0.62 |
| ▸ | PTGES | O14684 | 1/20 | 0.59 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.56 |
| ▸ | GAA | P10253 | 3/20 | 0.56 |
| ▸ | APP | P05067 | 2/20 | 0.56 |
| ▸ | TUBB1 | Q9H4B7 | 1/20 | 0.54 |
| ▸ | MET | P08581 | 3/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10085810 | 0.86 | PKM (0.87) | CYP2D6CYP1A2CYP2C9CYP3A4CYP2B6 | |
| SCHEMBL197850 | 0.86 | PKM (0.87) | CYP2D6CYP1A2CYP2C9CYP3A4CYP2B6 | |
| SCHEMBL29537849 | 0.86 | PKM (0.87) | CYP2D6CYP1A2CYP2C9CYP3A4CYP2B6 | |
| SCHEMBL14875206 | 0.85 | ALOX5 (0.80) | CYP2D6CYP1A2CYP2C9CYP3A4CYP2B6 | |
| SCHEMBL7158939 | 0.85 | EPHX2 (0.69) | CYP2D6CYP1A2CYP2C9CYP3A4CYP2B6 | |
| SCHEMBL14875201 | 0.85 | ALOX5 (0.80) | CYP2D6CYP1A2CYP2C9CYP3A4CYP2B6 | |
| SCHEMBL29566041 | 0.85 | ALOX5 (0.80) | CYP2D6CYP1A2CYP2C9CYP3A4CYP2B6 | |
| SCHEMBL6106506 | 0.82 | ALDH1A1 (0.74) | CYP2D6CYP1A2KDM4EGAATUBB1 | |
| SCHEMBL2743841 | 0.80 | CYP1A2 (1.00) | CYP2D6CYP1A2CYP2C9CYP3A4CYP2B6 | |
| SCHEMBL2743839 | 0.80 | CYP1A2 (1.00) | CYP2D6CYP1A2CYP2C9CYP3A4CYP2B6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1765761-B1 | NOVEL ANALOGS OF 3-O-ACETYL-11-KETO-BETA-BOSWELLIC ACID | LAILA NUTRACEUTICALS (IN) | 2013-04-03 | — | — | EP | claimed |
| US-20120035176-A1 | ANALOGS OF 3-O-ACETYL-11-KETO-BETA-BOSWELLIC ACID | LAILA NUTRACEUTICALS | 2012-02-09 | — | — | US | claimed |
| US-20090318551-A1 | USES OF ANALOGS OF 3-O-ACETYL-11-KETO-BETA-BOSWELLIC ACID | GOKARAJU GANGA RAJU | 2009-12-24 | — | — | US | claimed |
| US-7625947-B2 | Analogs of 3-O-acetyl-11-keto-β-boswellic acid | LAILA NUTRACEUTICALS (IN) | 2009-12-01 | — | — | US | claimed |
| EP-1765761-A1 | NOVEL ANALOGS OF 3-O-ACETYL-11-KETO-BETA-BOSWELLIC ACID | Gokaraju, Ganga, Raju (IN) | 2007-03-28 | — | — | EP | claimed |
| US-20060089409-A1 | Novel analogs of 3-o-acetyl-11-keto-ß-boswellic acid | LAILA NUTRACEUTICALS (IN) | 2006-04-27 | — | — | US | claimed |
| WO-2005123649-A1 | NOVEL ANALOGS OF 3-O-ACETYL-11-KETO-β-BOSWELLIC ACID | GOKARAJU GANGA RAJU (IN) | 2005-12-29 | — | — | WO | claimed |
| US-8748598-B2 | Analogs of 3-O-acetyl-11-keto-beta-boswellic acid | LAILA NUTRACEUTICALS (IN) | 2014-06-10 | — | — | US | disclosed |
| EP-1765761-B1 | NOVEL ANALOGS OF 3-O-ACETYL-11-KETO-BETA-BOSWELLIC ACID | LAILA NUTRACEUTICALS (IN) | 2013-04-03 | — | — | EP | disclosed |
| US-20120035176-A1 | ANALOGS OF 3-O-ACETYL-11-KETO-BETA-BOSWELLIC ACID | LAILA NUTRACEUTICALS | 2012-02-09 | — | — | US | disclosed |
| US-20090318551-A1 | USES OF ANALOGS OF 3-O-ACETYL-11-KETO-BETA-BOSWELLIC ACID | GOKARAJU GANGA RAJU | 2009-12-24 | — | — | US | disclosed |
| US-20090318551-A1 | USES OF ANALOGS OF 3-O-ACETYL-11-KETO-BETA-BOSWELLIC ACID | GOKARAJU GANGA RAJU | 2009-12-24 | — | — | US | disclosed |
| US-7625947-B2 | Analogs of 3-O-acetyl-11-keto-β-boswellic acid | LAILA NUTRACEUTICALS (IN) | 2009-12-01 | — | — | US | disclosed |
| US-7625947-B2 | Analogs of 3-O-acetyl-11-keto-β-boswellic acid | LAILA NUTRACEUTICALS (IN) | 2009-12-01 | — | — | US | disclosed |
| US-20060089409-A1 | Novel analogs of 3-o-acetyl-11-keto-ß-boswellic acid | LAILA NUTRACEUTICALS (IN) | 2006-04-27 | — | — | US | disclosed |
| US-20060089409-A1 | Novel analogs of 3-o-acetyl-11-keto-ß-boswellic acid | LAILA NUTRACEUTICALS (IN) | 2006-04-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120035176-A1 | ANALOGS OF 3-O-ACETYL-11-KETO-BETA-BOSWELLIC ACID | NFKBIA, ALOX12, ALOX15 | CYP2D6 1784/4885CYP1A2 886/4885CYP2C9 1505/4885 |
| US-20060089409-A1 | Novel analogs of 3-o-acetyl-11-keto-ß-boswellic acid | KAT2B, AKR1C3, ACACB | CYP2D6 1805/4885CYP1A2 2372/4885CYP2C9 2422/4885 |
| US-20090318551-A1 | USES OF ANALOGS OF 3-O-ACETYL-11-KETO-BETA-BOSWELLIC ACID | ACACB, KAT2B, AKR1C3 | CYP2D6 1638/4885CYP1A2 2166/4885CYP2C9 2496/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.